UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its stake in shares of Chimera Investment Co. (NYSE:CIM - Free Report) by 19.5% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 176,381 shares of the real estate investment trust's stock after purchasing an additional 28,760 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned approximately 0.22% of Chimera Investment worth $2,469,000 at the end of the most recent reporting period.
A number of other institutional investors have also recently added to or reduced their stakes in the stock. Quarry LP raised its position in shares of Chimera Investment by 1,691.7% during the 4th quarter. Quarry LP now owns 3,243 shares of the real estate investment trust's stock worth $45,000 after buying an additional 3,062 shares in the last quarter. New Age Alpha Advisors LLC purchased a new stake in Chimera Investment during the fourth quarter valued at about $56,000. Hillsdale Investment Management Inc. purchased a new position in Chimera Investment during the 4th quarter worth approximately $65,000. Summit Securities Group LLC acquired a new position in Chimera Investment during the fourth quarter valued at $111,000. Finally, Dynamic Technology Lab Private Ltd acquired a new stake in shares of Chimera Investment during the 4th quarter valued at $170,000. 48.44% of the stock is currently owned by institutional investors.
Chimera Investment Price Performance
CIM stock traded up $0.16 during trading on Tuesday, hitting $13.91. The company had a trading volume of 355,850 shares, compared to its average volume of 589,469. The company has a market cap of $1.13 billion, a P/E ratio of 12.88 and a beta of 1.75. Chimera Investment Co. has a fifty-two week low of $9.85 and a fifty-two week high of $16.89. The company has a current ratio of 0.06, a quick ratio of 3.03 and a debt-to-equity ratio of 2.82. The company has a fifty day moving average price of $12.40 and a two-hundred day moving average price of $13.56.
Chimera Investment (NYSE:CIM - Get Free Report) last posted its quarterly earnings data on Thursday, May 8th. The real estate investment trust reported $0.41 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.38 by $0.03. The firm had revenue of $69.22 million for the quarter, compared to the consensus estimate of $72.07 million. Chimera Investment had a return on equity of 7.00% and a net margin of 20.28%. Equities research analysts expect that Chimera Investment Co. will post 1.57 earnings per share for the current fiscal year.
Chimera Investment Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Wednesday, April 30th. Shareholders of record on Monday, March 31st were paid a $0.37 dividend. The ex-dividend date was Monday, March 31st. This represents a $1.48 dividend on an annualized basis and a yield of 10.64%. Chimera Investment's payout ratio is 98.67%.
Analysts Set New Price Targets
A number of research firms have issued reports on CIM. Royal Bank of Canada upgraded shares of Chimera Investment to a "moderate buy" rating in a research note on Friday, March 14th. Wall Street Zen upgraded shares of Chimera Investment from a "hold" rating to a "buy" rating in a report on Thursday, May 15th. Finally, UBS Group upgraded shares of Chimera Investment from a "neutral" rating to a "buy" rating and upped their price objective for the stock from $11.50 to $15.00 in a report on Wednesday, May 14th. Two research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $15.50.
Read Our Latest Stock Report on Chimera Investment
About Chimera Investment
(
Free Report)
Chimera Investment Corporation operates as a real estate investment trust (REIT) in the United States. The company, through its subsidiaries, invests in a portfolio of mortgage assets, including residential mortgage loans, agency residential mortgage-backed securities, non-agency residential mortgage-backed securities, agency mortgage-backed securities secured by pools of commercial mortgage loans, business purpose and investor loans, and other real estate related securities.
Featured Articles
Before you consider Chimera Investment, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Chimera Investment wasn't on the list.
While Chimera Investment currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
